Skip to content
QUANTRO Therapeutics GmbH logo — Discovery and development of novel therapeutics targeting tr...

QUANTRO Therapeutics GmbH

Discovery and development of novel therapeutics targeting transcription factors in cancer and other diseases

Founded 2019 Austria Austria 15 employees Total: $1.70M Biotechnology, Pharmaceutical

General Information

Company Name QUANTRO Therapeutics GmbH
Founded Year 2019
Location Austria Austria
Employees 15
Industries Biotechnology, Pharmaceutical
Business Model B2B, B2G
Revenue Model Licensing, Product Sales, Project Based
Social

BounceWatch is an independent company data service, not affiliated with QUANTRO Therapeutics GmbH. To contact QUANTRO Therapeutics GmbH, visit quantro-tx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does QUANTRO Therapeutics GmbH compare?

A PDF of QUANTRO Therapeutics GmbH and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting QUANTRO Therapeutics GmbH soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Grant Received Nov 03, 2026

QUANTRO Therapeutics received a 12-month research grant from the Austrian Research Promotion Agency to develop its AI platform, ASCEND.

Award Received Oct 27, 2026

QUANTRO Therapeutics was featured in the Starkes Land Österreich magazine published by DER SPIEGEL in Austria.

Event Participation Oct 23, 2026

An employee from QUANTRO Therapeutics will present a poster on their lead TEAD inhibitor program at the Drug Discovery Chemistry Europe conference in Barcelona.

About QUANTRO Therapeutics GmbH

QUANTRO Therapeutics GmbH, founded in 2019, is a pioneering biotechnology and pharmaceutical company based in Austria. The company is driven by its mission to revolutionize the slogan: "Discovery and development of novel therapeutics targeting transcription factors in cancer and other diseases".

The company emerges from Vienna's renowned Institute of Molecular Biotechnology and Research Institute of Molecular Pathology, leveraging advanced techniques like time-resolved RNA sequencing and comparative transcriptomics. These tools empower QUANTRO to tackle cancer-associated transcription factors, paving the way for innovative drug candidates previously beyond the reach of pharmacological intervention.

In its latest funding milestone, QUANTRO received a €1.70M grant from The Austrian Research Promotion Agency (FFG) as of 06 August 2024. This investment enhances their research and development capabilities, affirming their potential to address previously challenging targets in disease management.

Business keywords: Transcription Factors, Cancer Therapeutics, Drug Discovery, Comparative Transcriptomics, RNA Sequencing, Transcriptional Regulators, Pharmacologic Intervention, IMBA Spin-off, IMP Spin-off, Innovative Drug Pipeline, Disease-Causing Transcriptional Programs, Biopharmaceutical

Services & Products

Innovative Drug Discovery
Technology Development in Genetics and Transcriptomics
Precision Cell-based Screening

Target Customers

Pharmaceutical Companies Biotech Firms Research Institutions Healthcare Providers Cancer Treatment Centers

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed 1
Austrian Research Promotion Agency
01 Nov 2026
Grant €1.70M 1
Austrian Research Promotion Agency
01 Aug 2024
Spinout Undisclosed 2
Ology Capital, Austrian Academy of Sciences
01 Jan 2019

QUANTRO Therapeutics GmbH Alternatives & Competitors

View All Alternatives
QUANTRO Therapeutics GmbH vs
Frontier Medicines
Frontier Medicines United States

Frontier Medicines is a biopharmaceutical company that “drugs the undruggable” to transform patients...

Series C
80 employees
Biopharma, Biotechnology
QUANTRO Therapeutics GmbH vs
Cullgen Inc.
Cullgen Inc. United States

Powering protein degradation for tomorrow's medicines

Acquired
27 employees
Biotechnology, Pharmaceutical
QUANTRO Therapeutics GmbH vs
Acceleron Pharma
Acceleron Pharma United States

Accelerating drug discovery to transform patients' lives

Post-IPO Equity
67 employees
Biotechnology, Health Care

FAQ About QUANTRO Therapeutics GmbH

Discovery and development of novel therapeutics targeting transcription factors in cancer and other diseases
QUANTRO Therapeutics GmbH was founded in 2019.
QUANTRO Therapeutics GmbH is headquartered in Austria.
QUANTRO Therapeutics GmbH operates in Biotechnology and Pharmaceutical. Its work centres on Transcription Factors, Cancer Therapeutics, Drug Discovery and Comparative Transcriptomics. Its customers include Pharmaceutical Companies, Biotech Firms and Research Institutions.
QUANTRO Therapeutics GmbH has a B2B and B2G business model. Its revenue comes from Licensing, Product Sales and Project Based.
QUANTRO Therapeutics GmbH has approximately 15 employees.
QUANTRO Therapeutics GmbH has completed 3 funding rounds, raising a total of $1.70M.
QUANTRO Therapeutics GmbH offers: Innovative Drug Discovery, Technology Development in Genetics and Transcriptomics, Precision Cell-based Screening.
Top alternatives and competitors to QUANTRO Therapeutics GmbH include Frontier Medicines, Cullgen Inc., Acceleron Pharma, Laminar Pharma, Promatix Biosciences Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
QUANTRO Therapeutics GmbH and Frontier Medicines are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for QUANTRO Therapeutics GmbH, https://bouncewatch.com/company/quantro-therapeutics, updated 5 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout